Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease - PubMed (original) (raw)

Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease

V Solfrizzi et al. J Neurol Neurosurg Psychiatry. 2002 Jun.

Abstract

Objectives: To explore the possible role of serum lipoprotein(a) (Lp(a)), apolipoprotein E polymorphism, and total cholesterol (TC) serum concentrations in Alzheimer's disease (AD).

Methods: Lp(a) serum concentrations, apolipoprotein E genotypes, and TC serum concentrations were determined in 61 patients with a diagnosis of probable AD and in 63 healthy unrelated age matched controls. Genomic DNA was obtained and amplified by polymerase chain reaction and apolipoprotein E genotypes were defined following a previously described procedure.

Results: Lp(a) serum concentrations were significantly associated in a non-linear relation with an increased risk for AD, independently of apolipoprotein E genotypes and sex and dependent on age (truth association) and TC serum concentrations (spurious association). The effect of age adjusted for TC on the odds of having AD increased non-linearly with increasing Lp(a) serum concentrations, with a plateau between 70 and 355 mg/l (odds ratio 11.33). For Lp(a) serum concentrations > or = 360 mg/l, the effect of age (> or = 72 years) was associated with a reduction in odds of having AD (odds ratio 0.15).

Conclusion: It is suggested that increased Lp(a) serum concentrations, by increasing the risk for cerebrovascular disease, may have a role in determining clinical AD.

PubMed Disclaimer

Similar articles

• Lipid metabolism in cognitive decline and dementia.
  Panza F, D'Introno A, Colacicco AM, Capurso C, Pichichero G, Capurso SA, Capurso A, Solfrizzi V. Panza F, et al. Brain Res Rev. 2006 Aug;51(2):275-92. doi: 10.1016/j.brainresrev.2005.11.007. Epub 2006 Jan 10. Brain Res Rev. 2006. PMID: 16410024 Review.
• Apolipoprotein E polymorphism and serum lipoprotein(a) concentrations in a Korean male population.
  Chun S, Min WK, Kim JW, Park H, Jang S, Yang SE, Kim JQ. Chun S, et al. Ann Clin Biochem. 2001 Mar;38(Pt 2):129-34. doi: 10.1258/0004563011900434. Ann Clin Biochem. 2001. PMID: 11269753
• Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease.
  Emanuele E, Peros E, Tomaino C, Feudatari E, Bernardi L, Binetti G, Maletta R, D'Angelo A, Montagna L, Bruni AC, Geroldi D. Emanuele E, et al. Neurosci Lett. 2004 Feb 26;357(1):45-8. doi: 10.1016/j.neulet.2003.12.043. Neurosci Lett. 2004. PMID: 15036610
• Lipoproteins, vascular-related genetic factors, and human longevity.
  Panza F, D'introno A, Capurso C, Colacicco AM, Seripa D, Pilotto A, Santamato A, Capurso A, Solfrizzi V. Panza F, et al. Rejuvenation Res. 2007 Dec;10(4):441-58. doi: 10.1089/rej.2007.0537. Rejuvenation Res. 2007. PMID: 17990970 Review.
• Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease.
  Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto J, Nissinen A. Notkola IL, et al. Neuroepidemiology. 1998;17(1):14-20. doi: 10.1159/000026149. Neuroepidemiology. 1998. PMID: 9549720

Cited by

• Elevation of peripheral BDNF promoter methylation links to the risk of Alzheimer's disease.
  Chang L, Wang Y, Ji H, Dai D, Xu X, Jiang D, Hong Q, Ye H, Zhang X, Zhou X, Liu Y, Li J, Chen Z, Li Y, Zhou D, Zhuo R, Zhang Y, Yin H, Mao C, Duan S, Wang Q. Chang L, et al. PLoS One. 2014 Nov 3;9(11):e110773. doi: 10.1371/journal.pone.0110773. eCollection 2014. PLoS One. 2014. PMID: 25364831 Free PMC article.
• Plasma anti-α-galactoside antibody mediates lipoprotein(a) binding to macrophages.
  Sheela B, George G, Mandagini G, Appukuttan PS. Sheela B, et al. Glycoconj J. 2016 Dec;33(6):953-961. doi: 10.1007/s10719-016-9713-z. Epub 2016 Aug 19. Glycoconj J. 2016. PMID: 27540729
• Relationship between Lipoprotein (a) and cognitive function - Results from the Berlin Aging Study II.
  Röhr F, Bucholtz N, Toepfer S, Norman K, Spira D, Steinhagen-Thiessen E, Lill CM, Bertram L, Demuth I, Buchmann N, Düzel S. Röhr F, et al. Sci Rep. 2020 Jun 30;10(1):10636. doi: 10.1038/s41598-020-66783-3. Sci Rep. 2020. PMID: 32606300 Free PMC article.
• Lipoprotein(a) and risk of cognitive impairment in Black and White Americans: the Reasons for Geographic and Racial Differences in Stroke cohort.
  Arce Rentería M, McClure LA, Callas PW, LaBode-Richman VM, Kroll DS, Manly JJ, Zakai NA, Unverzagt F, Cushman M. Arce Rentería M, et al. Res Pract Thromb Haemost. 2023 Aug 8;7(6):102170. doi: 10.1016/j.rpth.2023.102170. eCollection 2023 Aug. Res Pract Thromb Haemost. 2023. PMID: 37694266 Free PMC article.
• Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study.
  He Q, Li Q, Zhao J, Wu T, Ji L, Huang G, Ma F. He Q, et al. Lipids Health Dis. 2016 Sep 5;15(1):146. doi: 10.1186/s12944-016-0320-6. Lipids Health Dis. 2016. PMID: 27595570 Free PMC article.

References

1. 1. Ann Intern Med. 2000 Apr 4;132(7):533-7 - PubMed
2. 1. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62 - PubMed
3. 1. Neurosci Lett. 2000 Oct 6;292(2):79-82 - PubMed
4. 1. J Neurol Neurosurg Psychiatry. 2001 May;70(5):699 - PubMed
5. 1. Br J Psychiatry. 1982 Jun;140:566-72 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • HighWire
  • Ovid Technologies, Inc.
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal